Keywords: Merck Serono. Merck KGaA, Movectro, Multiple sclerosis, Sun Pharma, Topotecan, Europe, EMA, GlaxoSmithKline, Hycamtin

Merck Serono pulls European application for oral MS drug Movectro; Sun withdraws topotecan

Article | 18 February 2011

Print This

The European Medicines Agency says it has been formally notified by Merck Serono Europe, a division of Germany’s ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in